TERT and cancer: More recently, with the discovery of immune checkpoint inhibitors that proved to have a potent antitumor immune response, improving the overall survival of patients in many cancer types, TERT vaccines have been evaluated in combination with immune checkpoint blockade in preclinical studies with promising results [75,76].